Purpose: To assess the ability of algorithmically assessed magnetic resonance imaging (MRI) features to predict the likelihood of upstaging to invasive cancer in newly diagnosed ductal carcinoma in situ (DCIS). Materials and Methods: We identified 131 patients at our institution from 2000-2014 with a core needle biopsyconfirmed diagnosis of pure DCIS, a 1.5 or 3T preoperative bilateral breast MRI with nonfat-saturated T 1 -weighted MRI sequences, no preoperative therapy before breast MRI, and no prior history of breast cancer. A fellowship-trained radiologist identified the lesion on each breast MRI using a bounding box. Twenty-nine imaging features were then computed automatically using computer algorithms based on the radiologist's annotation. Results: The rate of upstaging of DCIS to invasive cancer in our study was 26.7% (35/131). Out of all imaging variables tested, the information measure of correlation 1, which quantifies spatial dependency in neighboring voxels of the tumor, showed the highest predictive value of upstaging with an area under the curve (AUC) 5 0.719 (95% confidence interval [CI]: 0.609-0.829). This feature was statistically significant after adjusting for tumor size (P < 0.001). Conclusion: Automatically assessed MRI features may have a role in triaging which patients with a preoperative diagnosis of DCIS are at highest risk for occult invasive disease.
therapeutic implications of DCIS and invasive carcinoma differ, accurate detection of invasive cancer is clinically important. Decisions about surgery, neoadjuvant and/or adjuvant chemotherapy, radiation therapy, and hormone therapy all may be affected by the diagnosis rendered on CNB. [20] [21] [22] [23] It is important to identify which patients with a CNB-based diagnosis of DCIS are at risk for invasive disease in order to provide optimal medical care. Radiogenomics is an emerging field that investigates the relationship between genomic/pathology characteristics of disease and imaging phenotypes extracted by radiologists or computer algorithms. 24 National guidelines recommend the use of preoperative breast magnetic resonance imaging (MRI) for patients with either DCIS or invasive carcinoma in order to evaluate the extent of their disease. 20, 22 If an imaging marker predictive of DCIS upstaging to invasive carcinoma at surgery can be identified using routine imaging, clinicians may be able to better manage patients with underestimated invasive breast cancer. Previous work using radiologist-identified features has shown that MRI has the potential to diagnose occult invasive disease in DCIS patients. 7, 8, 13, 15, 19 The purpose of this study is to expand upon this previous work by assessing the ability of semiautomatically assessed MRI features to predict DCIS upstaging to invasive carcinoma at the time of surgery.
Materials and Methods

Patient Population
Institutional Review Board approval and waiver of informed consent were secured for this study. Using our electronic database we identified all women with pathology suggesting breast cancer and a contrast-enhanced breast MRI at our institution from January 1, 2000, through March 23, 2014 . We next identified patients who met the following eligibility criteria: CNB-confirmed DCIS without invasive cancer, a preoperative bilateral breast MRI with a nonfat-saturated T 1 -weighted MRI sequence, no neoadjuvant therapy before breast MRI, and no prior history of breast cancer. A flowchart of patient exclusions is show in Fig. 1 . The final cohort included patients with a postoperative pathologic diagnosis of either DCIS upstaged to invasive cancer (n 5 35) or DCIS only (n 5 96).
Imaging Data
Preoperative breast axial dynamic contrast-enhanced (DCE) MRI scans were acquired using 1.5T and 3.0T scanners in the prone position. Each study contained a precontrast nonfat-saturated T 1 -weighted, a fat-saturated gradient echo T 1 -weighted sequence, and a fatsaturated T 2 -weighted sequence. Between two and six dynamic postcontrast T 1 -weighted gradient echo series with fat suppression were obtained following intravenous administration of contrast. Specific information on the imaging protocols is in Table 1 . 
Image Annotation
Each case was annotated by one fellowship-trained breast-imaging radiologist with 1 year of experience (L.J.G.). For each case the reader identified one lesion (mass/nonmass enhancement) by drawing a 2D box around the lesion using an in-house graphical user interface (GUI). The reader then selected the range of slices that encompassed the totality of the lesion. The T 1 -weighted precontrast fat-saturated sequence, T 1 -weighted postcontrast fat-saturated sequence, and subtraction between these two sequences were provided to the reader through the GUI. The following information was provided to the radiologist to help identify the biopsied lesion: breast CNB location of the DCIS collected from the medical record and access to the MRI exam in our institution's picture archiving and communication system (PACS).
Computer-Based Image Segmentation and Feature Extraction
Based on the radiologist's annotation, the lesion was segmented using a fuzzy c-means (FCM) clustering algorithm 28 on the subtracted series of images, which are computed using the precontrast and first postcontrast sequence. The imaging features were then computed using the segmented tumor. It has been established earlier in the work of Esserman et al 29 that imaging features from MRI indicative of tumor size, distribution, and enhancement patterns for DCIS patients correlate with tumor biology. Hence, we extracted a set of imaging features pertaining to tumor morphology, textural properties, and enhancement in MRI for our investigation. A total of 29 imaging features were extracted from each case. The details of these features are as follows.
TUMOR MORPHOLOGIC FEATURES REPRESENTATIVE OF DIFFERENT ASPECTS OF TUMOR, SIZE, COMPACTNESS, APPEARANCE, AND DENSITY (9 FEATURES).
Algorithmically extracted major axis (indicative of tumor size), median value of lesion elongation (ratio of major axis to minor axis) over all slices, median solidity, median Euler number (measures of the compactness of the lesion voxels) over all slices, bounding ellipsoid volume ratio (BEVR), 30 bounding ellipsoid diameter ratio 1 (BEDR1), bounding ellipsoid diameter ratio 2 (BEDR2), margin fluctuation (MF), 31, 32 and angular standard deviation (ASD) 33 are computed to assess different shape and size-based properties of the lesions. These features are representative of different aspects of tumor, size, compactness, appearance, and density.
TUMOR TEXTURAL FEATURES QUANTIFYING TEXTURAL FEATURES OF THE LESION (16 FEATURES).
From the segmented tumor, the smallest convex polygon encompassing the 3D lesion is determined. Then a gray-level co-occurrence matrix (GLCM) is populated using the first postcontrast sequence, and the smallest convex polygon using all the voxels from the segmented lesion. Sixteen textural features 34 are then computed using this GLCM.
These features include autocorrelation, contrast, correlation, cluster prominence, cluster shade, dissimilarity, energy, entropy, homogeneity, maximum probability, sum average, sum variance, sum entropy, sum of squares variance, information measure of correlation 1 (IMC1), and information measure of correlation2. These textural features capture various aspects of tumor distribution inside the smallest convex polygon encompassing the 3D lesion after the segmentation.
MRI ENHANCEMENT FEATURES QUANTIFYING BREAST ENHANCEMENT DYNAMICS (4 FEATURES).
A total of three of these features are based on the background parenchyma enhancement quantifying the proportion of background parenchyma enhancing more than 10%, variance of the proportion of background parenchyma enhancing more than 10-100% in steps of 10%, and index of dispersion of the proportion of background parenchyma enhancing more than 10-100%. The fourth feature (F1) combines both lesion and parenchyma enhancement dynamics as mentioned in Mazurowski et al. 35 These enhancement dynamics features capture enhancement patterns of breast parenchyma, as well as tumor and parenchyma together.
Statistical Analysis
To test whether each of the examined imaging variables was associated with upstaging, we constructed a univariate logistic regression model for each of the variables, which gave us the unadjusted Pvalues. We then controlled for tumor size to ensure that the predictive value of the computer-extracted features is not simply reduced to this simple measurement. To do so, we constructed a twovariable logistic regression model for each imaging variable where the covariates were the imaging features and the tumor size, which gave us the adjusted P-values. The significance level for our study was 0.0017 (0.05/31), as we considered 31 features. To quantify how well each feature predicted upstaging, we calculated area under the receiver operating characteristic (ROC) curve (AUC) and associated confidence intervals (CIs). As an additional exploratory analysis, we evaluated the potential of a multivariate model for predicting upstaging, we first selected features using the entire dataset with a backward stepwise feature selection algorithm. Then we constructed a multivariate logistic regression model and evaluated it in a leave-one-out crossvalidation setting. We noted a potential bias to this approach due to the features being selected outside of the cross-validation loop. Therefore, the results correspond to an upper bound of an achievable performance given our sample size, which is appropriate due to the preliminary character of this analysis. To estimate the multivariate classifier performance, similarly as for the univariate analysis, we calculated the AUC with its CIs.
Results
The upstaging rate in the overall cohort was 26.7%. The clinicopathologic characteristics associated with DCIS upstaging and pure DCIS are shown in Table 2 . The association strength in terms of AUC performance for each of the analyzed imaging variables is shown in Fig. 2 and Table 3 . The features contrast, correlation1, dissimilarity, energy, entropy, homogeneity, max probability, sum entropy, and IMC1 all had a P-value of less than 0.05. After correcting for multiple hypothesis testing, the feature IMC1 still had a statistically significant P-value of 0.0008 after controlling for the tumor size in terms of the algorithmically computed major axis length of the tumor. Figure 3 shows two representative cases of DCIS and DCIS upstaged to invasive carcinoma with the corresponding values of the feature IMC1.
Higher absolute values of IMC1, which is indicative of higher dependence between all center voxels and their corresponding neighboring voxels inside the convex polygon bounding the tumor, denote a higher possibility of upstaging.
The exploratory analysis multivariate model showed no improvement as compared to the most predictive individual feature. The performance of the multivariate model was AUC 5 0.717 (95% CI: 0.814-0.620). We concluded that, given the limited sample size, there was no considerable improvement to be gained by combining the features. The features selected to the multivariate model were F1 (T 1 1 5 0.02, T 1 2 5 0.5), bounding ellipsoid volume ratio, autocorrelation, contrast, cluster prominence, cluster shade, dissimilarity, energy, homogeneity, maximum probability, sum variance, and IMC1. A total of 16 cases were excluded from the study because a lesion was not visible on MRI. None of these cases were upstaged to invasive carcinoma. Most of these patients had lesions that were small or did not have a lesion present at surgery with the following distribution: 7 out of the 16 patients had lesions that were measured at 1.0 cm or less at the time of surgery, four patients did not have DCIS present at surgery, three had lesions greater than 1.0 cm, and two had unavailable tumor size. The majority of these 16 patients had high-grade DCIS with the breakdown of grade as follows: zero were grade 1, four were grade 2, 11 were grade 3, and one had unavailable pathologic grade. Also, most these patients were ER-and PR-positive as follows: 12 ER-and PR-positive, three ER-and PR-negative, and one with unavailable hormone receptor data. The ER and PR breakdown of these 16 is similar to that of the rest AUC 5 area under the curve, NA 5 data not available. The adjusted P-value was determined by correcting for multiple hypothesis testing. The feature "major axis" was used as the control. The first block of features describe tumor morphology, the second block describes tumor texture, and the third block describes MRI enhancement.
of the DCIS-only patients with 75% being positive. More of these patients had high-grade disease (68.8%) as compared to the 51% in the rest of the DCIS-only cases.
Discussion
Upstaging of DCIS to invasive carcinoma has implications for treatment planning. In this dataset, the rate of upstaging from DCIS to DCIS with an invasive component was within the ranges previously identified [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] and similar to the average rate of upstaging found in Brennan et al 7 and Lee et al. 19 Our study shows that semiautomatically assessed MRI features may have a role in predicting patients with a preoperative diagnosis of DCIS who are at increased risk for having an invasive component to their disease. Several of the digitally extracted features had notable predictive value, but the feature IMC1 is the most promising out of all of the features. IMC1 computes the relationship between a voxel and its neighboring voxels from an information-theoretic point of view. The proximity of IMC1 to zero indicates that a voxel can be predicted with less certainty from the neighboring voxels. In our results, higher absolute values (hence, farther from zero) of IMC1 are indicative of upstaging. Therefore, for cases upstaged to invasive cancer a voxel can be predicted with higher certainty than that of DCIS. DCIS cases exhibit a sponge-like appearance, which increases the uncertainty in the prediction of neighboring voxels and therefore lower absolute values of IMC1 are obtained. However, for upstaging, the tumor has a more solid and smooth appearance, which increases the absolute value of IMC1.
Previous studies have examined several variables that may be predictive of DCIS with an invasive component including the following: clinical characteristics, 2, 10, 16, 17 histopathologic characteristics, 3, 4, [6] [7] [8] [9] [10] [11] [12] 16 and imaging characteristics. 2, 3, 5, 7, 9, 12, 13, 18 The imaging characteristics previously studied were the presence of a mass, enhancement kinetics, enhancement washout, lesion size on imaging, signal intensity on MRI, heterogeneous or rim enhancement pattern on MRI, and apparent diffusion coefficient (ADC). However, Lee et al 19 discussed that there have been inconclusive findings for several of these imaging features. Our study expanded on these previously investigated imaging variables by examining automatically assessed imaging features on MRI and showed that those features might be useful in prediction of upstaging of DCIS. There are major advantages to the use of automatically assessed features as opposed to subjective measures such as radiologist-perception based features. The algorithmic assessment of features allows for a more comprehensive and standardized assessment of tumor characteristics. The interobserver variability between radiologists is also mitigated by this approach, as opposed to perception-based measures. The radiologist's role in the use of these automatic features is to annotate a bounding box around the lesion of interest on the MRI. Although interobserver variability is still present in the algorithmic approach, the variability is alleviated by automatic segmentation of the tumor and the variability has been shown to not translate into considerable variability for the assessment of enhancement dynamics. 36 The use of these automatically assessed imaging features would minimally affect the workflow of the radiologist, while providing valuable information to the patient's treatment team. Our study is limited by its retrospective singleinstitution design and small sample size. Despite these limitations, we found that our automatically extracted MRI feature IMC1 was predictive of DCIS with an invasive component. Further validation and extension of these results in larger datasets is needed, which might reveal other prognostic variables or multivariate models superior to the one presented in this study. However, our analysis supports that automated image analysis of digital MRI images can predict the presence of concurrent invasive cancer with a high predictive value. Finally, the data used in this study spans 16 years, during which some changes were made to the imaging equipment. Some improvement in prognostic value of the imaging features could be seen in a more homogeneous cohort.
Please note that 16 patients were excluded from our analysis since they were not visible on MRI. None of these cases were upstaged to invasive carcinoma, suggesting that visibility of the lesion on MRI is strongly associated with upstaging, which is consistent with the results shown in Hwang et al. 37 The results presented in this study are applicable only to tumors that are visible on MRI. None of these cases were upstaged to invasive carcinoma, suggesting that visibility of the lesion on MRI is strongly associated with upstaging, which is consistent with the results shown in Hwang et al. 37 The results presented in this study are applicable only to tumors that are visible on MRI. Additional studies will be required to determine whether one or a group of automatically extracted radiologic features can accurately discriminate pure DCIS from DCIS with invasive cancer, and whether the performance of these features exceeds that of radiologist interpretation alone. Further, the value of this clinical information must be considered in light of the costs incurred by this additional testing, as well as which patients with DCIS would be most likely to benefit. This is especially a concern, as several studies have shown increased mastectomy rates associated with use of preoperative breast MRI. [38] [39] [40] The future role for such radiogenomic approaches could lie in their ability to mitigate the interobserver variability inherent in single radiologist interpretation, and the potential for their use as a component of integrated diagnostic tools that can be refined to predict tumor biology.
